DANBURY, Conn., April 24, 2017 - Addivantâ„˘, the world leading supplier of liquid phosphite antioxidants for plastics, announced today that its nonylphenol-free stabilizer, WESTONÂ® 705, has received formal approval from the U.S. Food and Drug Administration (FDA) for use in infant formula and human milk plastic packaging.
It covers the use of WESTONÂ® 705 at levels up to 2000 ppm in multiple types of polymers for repeat use articles intended for infant formula and breast milk, as well as in polymers intended for use with powdered infant formula.
â€śFDA has tightened even further its scrutiny on infant formulation using the most stringent screening procedures for this application,â€ť said John Steitz, Addivantâ€™s CEO. â€śWESTONÂ® 705 has been developed to surpass global regulatory standards providing a complete profile of its Non-Intentionally Added Substances (NIAS), allowing food packaging companies to stay ahead of the industry curve. This approval from the FDA for use in infant formula and human milk plastic applications confirms the unique benefits of this new generation of antioxidants in the most sensitive applications.â€ť
Already approved for use in more than 180 countries for food contact packaging, WESTONÂ® 705 is the only nonylphenol-free liquid phosphite antioxidant alternative with food contact approvals in the U.S., Canada, Europe, and China. This enables resin producers and packaging manufacturers to employ a single, global solution for Consumer Packaged Goods customers looking to stay ahead of the regulatory curve. The result of more than seven years of research and investment, WESTONÂ®705 is the most thoroughly tested new plastic antioxidant on the market today.
Addivantâ„˘ is dedicated to Responsible CareÂ®, the chemical industryâ€™s initiative to protect the environment; while ensuring the safety and security of our operations; and safeguarding the health and safety of our employees and neighboring communities. The goal is to make continuous progress toward the vision of no accidents, injuries or harm to the environment. As active and responsible members of the communities in which we operate, Addivantâ„˘ is committed to open communication with our employees and neighbors. The company monitors the safe production, transportation, and use of its products. Employees are comprehensively trained to do their jobs safely and with minimum impact on the environment. We care about the future â€” for all of us. To learn more about WESTONÂ® 705, visit https://www.weston705.com/.
Addivantâ„˘ is an innovator in the field of polymer additives, developing customized solutions that provide customers enhanced application performance, safe handling, and reduction in cost of use. The company is recognized industry-wide for its extensive portfolio of specialty additives including antioxidants, light stabilizers, rubber additives, polymer modifiers, metal deactivators, polymerization inhibitors, and intermediates. Addivant is an international company with 11 plants on five continents, as well as research, manufacturing, and sales facilities around the globe. The company maintains its global headquarters in Connecticut, USA, with regional headquarters in Al Jubail, Saudi Arabia, Basel, Switzerland, and Shanghai, China. Addivant is an independent portfolio company of SK Capital. Visit www.addivant.com for more information.
About SK Capital
SK Capital is a private investment firm with a disciplined focus on the specialty materials, chemicals, and healthcare sectors. The firmâ€™s purpose is to build strong and growing businesses that create substantial long-term economic value. SK utilizes its industry, operating and investment experience to identify opportunities to transform businesses into higher performing organizations with improved strategic positioning, growth and profitability as well as lower operating risk. SK Capitalâ€™s portfolio companies generate revenues of approximately $8 billion annually and employ approximately 9,000 people. The firm currently manages more than $1.5 billion of committed capital. Visit www.skcapitalpartners.com for more information.
+1 203 702 6182
+32 479 456 386
+86 21 6032 6822